_WHAT’S HAPPENING_
Early on in the second Trump administration, President Donald Trump and Health and Human Services Secretary (HHS) Robert F. Kennedy, Jr. embarked on an agenda to lower drug prices to match what other countries pay.
This past week, Trump announced new developments in his endeavor.
Insider Analysis Locked
Every daily article includes insider analysis you won’t find anywhere else—sharp, uncensored, and ahead of the curve.
See insights for this story